Bone marrow resident NK cells exhibit a unique immunosuppressive phenotype with higher surface CXCR6 and express higher levels of TIGIT than circulating NK cells at steady state, suggesting anti-TIGIT approaches may be particularly important for treatment of hematologic malignancies (67). Here, TIGIT is linked to hematologic disorder.